Company intelligence / Profile preview

Coval Energy

Ownership: Private
Development stage: Preclinical

Overview

Coval Energy develops and demonstrates technologies to convert captured carbon dioxide into sustainable fuels, chemicals, and proteins using renewable electricity. Their demo plant can process up to 0.1 ton CO₂/hour with a production volume of up to 14 tons formate per year. No clinical results as the company is not in healthcare.

Industry: Non-Drug Biotech

Partnerships

Strategic partners and third-party investors support spin-out ventures but no major pharma/biotech partnerships reported

Beyond the preview

Go deeper on Coval Energy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coval Energy.

Explore the full profile